Navigation Links
Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
Date:1/29/2008

Company incorporates in U.S., grows network of partner clinics, fits dozens

of patients

BOSTON, MA and LIVINGSTON, Scotland, Jan. 29 /PRNewswire/ - Touch Bionics, developer of the world's first commercially available bionic hand, today announced its incorporation in the United States as Touch Bionics, Inc. Currently basing U.S. operations out of Boston, MA, this announcement follows the company's opening of its new headquarters and leading-edge development and manufacturing facility in the United Kingdom earlier this month.

"Having a stronger U.S. presence enables Touch Bionics to better serve its growing network of partner clinics in America, the company's biggest market," said Touch Bionics CEO Stuart Mead. "With more U.S. clinics offering the i-LIMB Hand, growing numbers of American amputees will have the option of being fitted with the most advanced prosthetic hand on the market. The fact that we're at the top end of our sales projections shows there is a ready market for our product."

Since the launch of the i-LIMB Hand in July 2007, more than 70 patients worldwide have been fitted, and the company anticipates reaching the milestone of 100 fitted patients by the end of February 2008. In order to serve the prosthetics market worldwide, Touch Bionics has built relationships with a wide range of clinical companies, from the world's largest to smaller, independent clinics, both ends of the scale represent important areas of business for the company.

"My experience working with Touch Bionics has been that the company is very credible, reliable and responsive and that the company's primary interest is patient care," said Jake Wood, C.P., F.A.A.O.P, sole certified prosthetist and co-owner at Orthotics and Prosthetics Associates, Inc. in Milwaukee, WI. "I am so appreciative of what they have made available for my patients. Touch Bionics technology allows me to do my job better, providing patients with a s
'/>"/>

SOURCE TOUCH BIONICS
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
2. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
3. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
4. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
5. PPD Expands Global Central Lab Services into China
6. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
7. Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
8. Ventria Expands Team and Hires Kansan as Director of Bioprocessing Operations
9. Symmetry Medical Expands Board of Directors
10. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
11. Observant LLC Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
(Date:12/1/2009)NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Chromium - Global Market Trends ,, http://www.reportlinker.com/p0164494/Chromium--
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
... Pa., Feb. 18 Jennifer Brownstein, Art Director a...09 Rising Star by the Healthcare Businesswomen,s A...ng professionals in various sectors of the healthc...ogy, advertising, public relations, medical educat...rate members, Rising Stars represent various caree...
...HOUSAND OAKS, Calif., Feb. 18 Amgen Inc. (Nasdaq:...rug Administration (FDA) has accepted Amgen,s subm...BLA) for denosumab, an investigational RANK Ligand...eking FDA approval are treatment and prevention of...eatment and prevention of bone loss in patients un...
... Finder to Speed up the Peer Review Process! , , ...TC Bulletin Board: CLXS), a leading developer of s...nnounced today that the American Association for C...eviewer Finder and Journal Dashboard applications ...o: http://www.newscom.com/cgi-bin/prnh/20090107/...
Other Biology Technology:Jennifer Brownstein, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 3FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 4FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 5FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 6American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 2American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 3
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 1Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 2Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 3Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 4Research from Dr Charles Gerba Finds Average Toilet Paper 26 Towel Dispensers Have More Bacteria Than Average Toilet Seat 49260 1Research from Dr Charles Gerba Finds Average Toilet Paper 26 Towel Dispensers Have More Bacteria Than Average Toilet Seat 49260 2Research from Dr Charles Gerba Finds Average Toilet Paper 26 Towel Dispensers Have More Bacteria Than Average Toilet Seat 49260 3The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 1The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 3
...lside Hospital campus of The Feinstein Institute f...ene that appears to influence intelligence. Workin...ers Center for Genetics and Genomics in Boston, th...ints of individuals with schizophrenia, a neuropsy...rment, and compared them with healthy volunteers. ...
...t to mention the cleaning product industry, repeat...ity School of Medicine microbiologist is raising t...iral infections have benefits. , Stanley Falkow, P...n Cancer Research, is publishing his thoughts on t...journal Cell, in which he asks, "Is persistent bac...
...the world has revealed that nature encourages biod...es. The landmark study, conducted by 33 ecologists...sue of the journal Science, conclusively demonstra...rtance to tropical forests. , Helene Muller-Landau...ity of Minnesota,s College of Biological Sciences,...
Other Biology News:Feinstein researchers identify intelligence gene 2Learning to love bacteria: Stanford scientist highlights bugs' benefits 2Learning to love bacteria: Stanford scientist highlights bugs' benefits 3Underdogs in the understory: Study suggests nature favors rarer trees 2
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
GenomePlex Whole Genome Amplification (WGA) kit from Sigma-Aldrich
...r Vector is a derivative of the pAcHLT-A Vector (C...orescent protein (BFP), followed by a 6xHis tag an... expressed as BFP-6xHis fusion proteins when clone...es (EcoR I, Stu I, Sac I, Not I, Pst I, Kpn I, Sma...
Histology, Immunohistochemistry & Tissue Array Services from Dominion Pharmakine S.L.
Biology Products: